JP2014535050A - 生体試料におけるゲノム再編成を特定又は検出する方法 - Google Patents

生体試料におけるゲノム再編成を特定又は検出する方法 Download PDF

Info

Publication number
JP2014535050A
JP2014535050A JP2014537743A JP2014537743A JP2014535050A JP 2014535050 A JP2014535050 A JP 2014535050A JP 2014537743 A JP2014537743 A JP 2014537743A JP 2014537743 A JP2014537743 A JP 2014537743A JP 2014535050 A JP2014535050 A JP 2014535050A
Authority
JP
Japan
Prior art keywords
probe
short
sequence
genomic
probes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014537743A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014535050A5 (https=
Inventor
旬 小松
旬 小松
ワルラフェン ピエール
ワルラフェン ピエール
セッピ マウリジオ
セッピ マウリジオ
コンセイレル エマヌエル
コンセイレル エマヌエル
Original Assignee
ゲノミク ビジョン
ゲノミク ビジョン
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ゲノミク ビジョン, ゲノミク ビジョン filed Critical ゲノミク ビジョン
Publication of JP2014535050A publication Critical patent/JP2014535050A/ja
Publication of JP2014535050A5 publication Critical patent/JP2014535050A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/10—Detection mode being characterised by the assay principle
    • C12Q2565/102—Multiple non-interacting labels
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2014537743A 2011-10-31 2012-10-30 生体試料におけるゲノム再編成を特定又は検出する方法 Pending JP2014535050A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161553889P 2011-10-31 2011-10-31
US61/553,889 2011-10-31
PCT/IB2012/002423 WO2013064896A1 (en) 2011-10-31 2012-10-30 Method for identifying or detecting genomic rearrangements in a biological sample

Publications (2)

Publication Number Publication Date
JP2014535050A true JP2014535050A (ja) 2014-12-25
JP2014535050A5 JP2014535050A5 (https=) 2016-08-18

Family

ID=47559567

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014537743A Pending JP2014535050A (ja) 2011-10-31 2012-10-30 生体試料におけるゲノム再編成を特定又は検出する方法

Country Status (4)

Country Link
US (3) US9133514B2 (https=)
EP (1) EP2773770A1 (https=)
JP (1) JP2014535050A (https=)
WO (1) WO2013064896A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014532403A (ja) * 2011-10-31 2014-12-08 ゲノミク ビジョン ゲノムモールスコードを分子コーミングと併用する乳癌及び卵巣癌遺伝子並びに遺伝子座ｂｒｃａ１及びｂｒｃａ２におけるゲノム再編成の検出、可視化、及び高解像度物理マッピングの方法
US10227650B2 (en) 2014-11-14 2019-03-12 Athena Diagnostics, Inc. Methods to detect a silent carrier of a null allele genotype
US20180150597A1 (en) * 2016-11-29 2018-05-31 Genomic Vision Sa Method for optimal design of polynucleotides sequences for analysis of specific events in any genetic region of interest
US20220064742A1 (en) 2018-11-30 2022-03-03 Genomic Vision Association between integration of viral as hpv or hiv genomes and the severity and/or clinical outcome of disorders as hpv associated cervical lesions or aids pathology

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001507929A (ja) * 1996-10-30 2001-06-19 アンスティテュ、パストゥール 分子コーミングによる遺伝病の診断法および診断用キット
JP2010502206A (ja) * 2006-09-07 2010-01-28 アンスティテュ・パストゥール 遺伝子モールスコード
WO2011132078A2 (en) * 2010-04-23 2011-10-27 Genomic Vision Diagnosis of viral infections by detection of genomic and infectious viral dna by molecular combing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828097B1 (en) 2000-05-16 2004-12-07 The Childrens Mercy Hospital Single copy genomic hybridization probes and method of generating same
US20030017159A1 (en) * 2001-05-02 2003-01-23 Jerome Ritz Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
WO2005123961A2 (en) * 2004-06-14 2005-12-29 Ambry Genetics Corporation Approaches to identifying mutations associated with hereditary nonpolyposis colorectal cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001507929A (ja) * 1996-10-30 2001-06-19 アンスティテュ、パストゥール 分子コーミングによる遺伝病の診断法および診断用キット
JP2010502206A (ja) * 2006-09-07 2010-01-28 アンスティテュ・パストゥール 遺伝子モールスコード
WO2011132078A2 (en) * 2010-04-23 2011-10-27 Genomic Vision Diagnosis of viral infections by detection of genomic and infectious viral dna by molecular combing

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Cancer Research", 2005, VOL.65, NO.4, PP.1174-1179, JPN6016012551, ISSN: 0003633038 *
S GAD: "Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French bre", J. MED. GENET., vol. 39, JPN6016035387, 2002, pages 817 - 821, XP055054670, ISSN: 0003633036, DOI: 10.1136/jmg.39.11.817 *
SOPHIE GAD: "Color Bar Coding the BRCA1 Gene on Combed DNA: A Useful Strategy for Detecting Large Gene Rearrangem", GENES, CHROMOSOMES & CANCER, vol. 31, JPN6016035389, 2001, pages 75 - 84, XP071949262, ISSN: 0003633037, DOI: 10.1002/gcc.1120 *

Also Published As

Publication number Publication date
EP2773770A1 (en) 2014-09-10
WO2013064896A1 (en) 2013-05-10
US9133514B2 (en) 2015-09-15
US20180100202A1 (en) 2018-04-12
US20140011194A1 (en) 2014-01-09
US20160032405A1 (en) 2016-02-04

Similar Documents

Publication Publication Date Title
Ferrari et al. A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers
US20260002218A1 (en) Personalized tumor biomarkers
Nones et al. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis
Cottrell et al. Validation of a next-generation sequencing assay for clinical molecular oncology
EP2663652B1 (en) High resolution melting analysis as a prescreening tool
JP2000511433A (ja) 前立腺癌に関連する遺伝子の変化
JP7631400B2 (ja) 遺伝子調節
Alcaide et al. Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits
WO2021253138A1 (en) Multimodal analysis of circulating tumor nucleic acid molecules
CN104894256B (zh) 检测乙醛脱氢酶2基因rs671多态性位点的引物、试剂盒及其PCR方法
US20180340235A1 (en) Methods for the detection, visualization and high resolution physical mapping of genomic rearrangements in breast and ovarian cancer genes and loci brca1 and brca2 using genomic morse code in conjunction with molecular combing
US20250084486A1 (en) Frequent egfr and ntrk somatic mutations in colorectal cancer (crc) with microsatellite instability (msi)
JP2023523002A (ja) 染色体近接実験における構造的変異検出
US20180100202A1 (en) Method for identifying or detecting genomic rearrangements in a biological sample
CN104862401B (zh) 检测kras基因热点突变位点的引物、试剂盒及其pcr方法
Loftus et al. A custom capture sequence approach for oculocutaneous albinism identifies structural variant alleles at the OCA2 locus
Oldfield et al. An integrative DNA sequencing and methylation panel to assess mismatch repair deficiency
McClinton et al. Targeted nanopore sequencing enables complete characterisation of structural deletions initially identified using exon‐based short‐read sequencing strategies
Yao et al. Mutational landscape of triple-negative breast cancer in African American women
US20150344966A1 (en) Hereditary Cancer Diagnostics
Pokorna et al. Real-World Performance of Integrative Clinical Genomics in Pediatric Precision Oncology
Rai et al. Molecular profiling of Gynaecological Cancer and breast Cancer
Rowsey et al. Whole-genome single nucleotide polymorphism microarray for copy number and loss of heterozygosity analysis in tumors
Tamber et al. Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies
US20130084564A1 (en) Assessment of cancer risk based on rnu2 cnv and interplay between rnu2 cnv and brca1

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141008

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151029

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151029

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160630

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160913

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20161208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170310

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170905

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171201

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180302

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180703